HYL · Hyloris Pharmaceuticals
Market Cap
124.60M EUR
Shares
28.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close4.0800 EUR
Open4.2000 EUR
Day4.0800–4.2000 EUR
52W close4.0500–8.1000 EUR
Avg vol 30d3K
Last earningsMar 25, 2027
DataJun 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 4.0500 EUR
Now 4.0800 EUR · 1%
Range high 8.1000 EUR
vs 200-day avg -26%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XBRU:HYL | -6.2% | -7.3% | -32.2% | -5.3% | -40.4% |
Exchange listing
- Market
- XBRU
- Ticker
- HYL
- ISIN
- BE0974363955
- Security
- —
- Trading currency
- EUR
Company
- Website
- https://hyloris.com/
- Investor relations
- https://www.hyloris.com/investors
Other listings of this company
No other verified listings are available.
Latest trade
15-minute delayed Session complete4.0800 EUR
6 shares at 2026-10-05 15:35:20 UTC (17:35:20 local)
- Session
- 2026-10-05
- Open
- 4.2000
- High
- 4.2000
- Low
- 4.0800
- Volume
- 1,745
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2027-03-25 00:00 UTC | 2026 Annual Results | Results publication |
| 2027-04-30 00:00 UTC | 2026 Annual Report | Event |
| 2027-06-08 00:00 UTC | Annual General Meeting of Shareholders | Shareholder meeting |
Earnings calls
-
Earnings call · Q4 2026 2027-03-25 Scheduled2026 Annual Results
-
Earnings call · Q2 2026 2026-09-242026 Half-Year Results